Literature DB >> 20336357

Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats.

Claire Boland1, Valérie Collet, Emmanuelle Laterre, Corinne Lecuivre, Xavier Wittebole, Pierre-François Laterre.   

Abstract

The cholinergic anti-inflammatory pathway has been identified as playing a key role in the communication between the central nervous system and the immune system during inflammation. The potential beneficial role of vagus nerve stimulation (VNS) remains to be clarified in established sepsis. We hypothesized that VNS or nicotine administration would reduce lung injury and mortality in established sepsis. We conducted a prospective, randomized experimental study. Four hours after peritonitis induction by cecal ligation and puncture (CLP), rats were randomized into three groups of seven animals according to the intervention: control group, VNS group (15 V, 2 ms, 5 Hz during 20 min), and nicotine group (400 µg/kg intraperitoneal). Survival was determined as lung injury score 4 and 8 h after CLP. Tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, IL-10, cytokine-induced neutrophil chemoattractant (CINC)-3 and thrombin-antithrombin complexes (TATc) were measured at baseline and at 4 and 8 h after CLP. Survival at 8 h was 71.4%, 100%, and 23.8% in the control, VNS, and nicotine groups, respectively (p < 0.05). All animals had lung damage but without significant difference between groups even if nicotine-treated animals tended to have a higher score than the controls (p = 0.09). Neutrophil polymorphonuclear (PMN) infiltration was more pronounced in the nicotine group compared with the VNS group (p = 0.015) but not with the controls. TNF-α, IL-6, IL-10, CINC-3, and TATc were elevated in all groups (NS). In this model of established sepsis, posttreatment by VNS was associated with increased survival, while nicotine administration increased lung PMN infiltration and mortality. Nicotine-induced bacterial clearance impairment and nicotine systemic effects may explain these observations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20336357     DOI: 10.1007/s10753-010-9204-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  Analysis of the relationship between drug-induced convulsions and mortality in rats.

Authors:  B BLUM; S ZACKS
Journal:  J Pharmacol Exp Ther       Date:  1958-12       Impact factor: 4.030

Review 2.  Bidirectional relation between inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll; Harry R Büller
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

3.  Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway.

Authors:  Wouter J de Jonge; Esmerij P van der Zanden; Frans O The; Maarten F Bijlsma; David J van Westerloo; Roelof J Bennink; Hans-Rudolf Berthoud; Satoshi Uematsu; Shizuo Akira; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Nat Immunol       Date:  2005-07-17       Impact factor: 25.606

4.  Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats.

Authors:  D J van Westerloo; I A J Giebelen; J C M Meijers; J Daalhuisen; A F de Vos; M Levi; T van der Poll
Journal:  J Thromb Haemost       Date:  2006-06-29       Impact factor: 5.824

5.  Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.

Authors:  Stefan Hofer; Christoph Eisenbach; Ivan K Lukic; Lutz Schneider; Konrad Bode; Martina Brueckmann; Sven Mautner; Moritz N Wente; Jens Encke; Jens Werner; Alexander H Dalpke; Wolfgang Stremmel; Peter P Nawroth; Eike Martin; Peter H Krammer; Angelika Bierhaus; Markus A Weigand
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

Review 6.  Inflammation and coagulation: implications for the septic patient.

Authors:  R Phillip Dellinger
Journal:  Clin Infect Dis       Date:  2003-05-08       Impact factor: 9.079

7.  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.

Authors:  Jared M Huston; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Renqi Yuan; Mauricio Rosas-Ballina; Mala Ashok; Richard S Goldstein; Sangeeta Chavan; Valentin A Pavlov; Christine N Metz; Huan Yang; Christopher J Czura; Haichao Wang; Kevin J Tracey
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

8.  The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.

Authors:  Xue-Min Song; Jian-Guo Li; Yan-Lin Wang; Zheng-Fang Hu; Qing Zhou; Zhao-Hui Du; Bao-Hui Jia
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

9.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

10.  Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock.

Authors:  Salvatore Guarini; Domenica Altavilla; Maria-Michela Cainazzo; Daniela Giuliani; Albertino Bigiani; Herbert Marini; Giovanni Squadrito; Letteria Minutoli; Alfio Bertolini; Rolando Marini; Elena B Adamo; Francesco S Venuti; Francesco Squadrito
Journal:  Circulation       Date:  2003-03-04       Impact factor: 39.918

View more
  17 in total

Review 1.  Rethinking inflammation: neural circuits in the regulation of immunity.

Authors:  Peder S Olofsson; Mauricio Rosas-Ballina; Yaakov A Levine; Kevin J Tracey
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Neural control of the immune system.

Authors:  Eva Sundman; Peder S Olofsson
Journal:  Adv Physiol Educ       Date:  2014-06       Impact factor: 2.288

Review 3.  Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis.

Authors:  Alexandre Kanashiro; Fabiane Sônego; Raphael G Ferreira; Fernanda V S Castanheira; Caio A Leite; Vanessa F Borges; Daniele C Nascimento; David F Cólon; José Carlos Alves-Filho; Luis Ulloa; Fernando Q Cunha
Journal:  Pharmacol Res       Date:  2016-12-12       Impact factor: 7.658

4.  Vagus Nerve Stimulation for Treatment of Inflammation: Systematic Review of Animal Models and Clinical Studies.

Authors:  Harwood Kwan; Luca Garzoni; Hai Lun Liu; Mingju Cao; Andre Desrochers; Gilles Fecteau; Patrick Burns; Martin G Frasch
Journal:  Bioelectron Med       Date:  2016-09-14

5.  Attenuation of hyperoxia-induced lung injury in rats by adrenomedullin.

Authors:  Wei Tao; Yu-Sheng Shu; Qian-Bing Miao; Ya-Bing Zhu
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Pharmacological Beta-Adrenergic Receptor Activation Attenuates Neutrophil Recruitment by a Mechanism Dependent on Nicotinic Receptor and the Spleen.

Authors:  Rangel L Silva; Fernanda V Castanheira; Jozi G Figueiredo; Gabriel S Bassi; Sérgio H Ferreira; Fernando Q Cunha; Thiago M Cunha; Alexandre Kanashiro
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

7.  Effects of vagus nerve stimulation and vagotomy on systemic and pulmonary inflammation in a two-hit model in rats.

Authors:  Matthijs Kox; Michiel Vaneker; Johannes G van der Hoeven; Gert-Jan Scheffer; Cornelia W Hoedemaekers; Peter Pickkers
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

Review 8.  The vagal innervation of the gut and immune homeostasis.

Authors:  Gianluca Matteoli; Guy E Boeckxstaens
Journal:  Gut       Date:  2012-09-29       Impact factor: 23.059

9.  Vagus nerve through α7 nAChR modulates lung infection and inflammation: models, cells, and signals.

Authors:  Haiya Wu; Ling Li; Xiao Su
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 10.  Potential effects of medicinal plants and secondary metabolites on acute lung injury.

Authors:  Daniely Cornélio Favarin; Jhony Robison de Oliveira; Carlo Jose Freire de Oliveira; Alexandre de Paula Rogerio
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.